The Duke Prostate Center is on the forefront of prostate cancer research and treatment. See news articles featuring the Duke Prostate Center.
Medical Bills Force Cancer Patients to Skimp on Care and Necessities (DukeHealth.org)
June 6, 2011
Even when covered by health insurance, cancer patients face mounting out-of-pocket expenses that force some to avoid filling prescriptions, skip doctor appointments and scale back on food and other necessities.
Blood Thinner May Protect Cancer Patients from Potentially Fatal Clots (DukeHealth.org)
June 6, 2011
A new type of anti-clotting drug called semuloparin has been found to reduce the development of potentially fatal blood clots in the veins that often occur in cancer patients, doctors at Duke Cancer Institute and elsewhere reported today.
Pioneering Cancer Researcher Will Lead the New Duke Cancer Institute (DukeHealth.org)
May 16, 2011
Michael B. Kastan, MD, PhD, a renowned cancer scientist and director of the Comprehensive Cancer Center at St. Jude Children's Research Hospital, has been named the executive director of the Duke Cancer Institute.
Obesity Linked to Higher Risk of Prostate Cancer Progression (DukeHealth.org)
May 15, 2011
Even when treated with hormone therapy to suppress tumor growth, obese men face an elevated risk of their prostate cancer worsening, researchers at Duke University Medical Center have found.
Blocking the Critical Structure that Lets Cancer Cells Move -- Their Feet (DukeHealth.org)
Dec. 16, 2010
Scientists now know that some cancer cells spread, or metastasize, throughout the body the old-fashioned way -- by using their feet. But researchers at Duke Cancer Institute have discovered a way to short-circuit their travels by preventing the development of these feet, called invadopodia. This discovery is even more important because blocking these "feet" also blocks proteins in the feet that burn through intact tissue and let cancer cells enter new cells.
Scientists Decode Secrets of a Very Common Virus that Can Cause Cancer (DukeHealth.org)
Dec. 16, 2010
About 90 percent of people are infected at some time in their lives with Epstein-Barr virus (EBV), usually with no ill effects. But individuals with compromised immune systems, such as people with organ transplants or HIV infection, have a greater risk of cancer occurring because of this virus.
National Cancer Institute Renews Duke Comprehensive Cancer Center Core Grant (DukeHealth.org)
Sept. 14, 2010
The Duke Comprehensive Cancer Center (DCCC) has received a 5-year, $30 million core grant renewal from the National Cancer Institute (NCI) to support its broad range of clinical, research, and educational programs designed to lessen the impact of cancer upon the lives of people throughout North Carolina and beyond.
Alphavirus-Based Vaccine May Slow Some Cancers (DukeHealth.org)
Aug. 2, 2010
An experimental vaccine based on a virus that causes encephalitis in the wild appears to block tumor growth in some cases of advanced cancer, according to researchers at Duke University Medical Center.
Duke and Bulls Join to Strike Out Cancer (DukeHealth.org)
July 29, 2010
The Duke Comprehensive Cancer Center and the Durham Bulls have joined together for the 2nd year to “Strike Out Cancer” (SOC). The program is designed to raise awareness for cancer and funds to support cancer research at Duke.
Online Tools Provide Insight for Prostate Cancer Patients (DukeHealth.org)
July 16, 2010
Patients with prostate cancer now have two new interactive web tools known as risk calculators to help them better understand their disease.
Contact Us
|
Careers
|
Make a Gift
|
Site Map
